Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

341
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
341
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

232
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
232
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

664
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
664
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurosteroids in Neurological and Psychiatric Disorders: Therapeutic Implications.

CNS & neurological disorders drug targets·2026
Same author

Multifactorial Neuroprotective Potential of γ-Aminobutyric acid-Producing Potential Probiotics Against Stress Induced Neuronal Cell Lines.

Probiotics and antimicrobial proteins·2026
Same author

Mechanistic exploration of methylglyoxal-induced hepatotoxicity involving oxidative stress, apoptosis, and gluconeogenic modulation.

Chemico-biological interactions·2026
Same author

Astroglia and depression: A Gliocentric perspective from rodent models to therapeutic insights.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Ambroxol rescues cognitive impairment by ameliorating oxidative stress and autophagic dysfunction in the streptozotocin-induced Alzheimer's disease model.

European journal of pharmacology·2025
Same author

Exploration of biomaterial and stem cell-based strategies for promoting neuronal regeneration and creating engineered 3D in-vitro disease models.

Journal of translational medicine·2025

Related Experiment Video

Updated: Aug 29, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Artificial Intelligence in Efficient Diabetes Care.

Gopal Bhagwan Khodve1, Sugato Banerjee1

  • 1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Kolkata, India.

Current Diabetes Reviews
|September 6, 2022
PubMed
Summary

This review examines how advanced computational systems and machine learning tools improve the management of diabetes. By analyzing current technologies, the authors highlight how these innovations assist in glucose monitoring, insulin delivery, and the prevention of long-term health complications. The article also discusses how these digital solutions support healthcare providers in making more accurate clinical decisions.

Keywords:
Artificial intelligencecontinuous glucose monitoringdiabetesdiabetes managementhealthcaremachine learningdigital healthglucose monitoringpredictive modelingmetabolic care

Frequently Asked Questions

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization
05:49

Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization

Published on: February 23, 2024

957

Related Experiment Videos

Last Updated: Aug 29, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization
05:49

Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization

Published on: February 23, 2024

957

Area of Science:

  • Endocrinology and metabolism research within Artificial Intelligence clinical applications
  • Digital health and chronic disease management informatics

Background:

Chronic metabolic disorders remain difficult to eliminate, necessitating long-term therapeutic strategies for patient stability. No prior work had resolved the full scope of digital integration within routine clinical workflows. That uncertainty drove interest in how computational models might alleviate the burden of constant self-care. Prior research has shown that suboptimal glucose regulation frequently results in severe systemic damage to nerves, kidneys, and ocular tissues. This gap motivated a comprehensive assessment of emerging technological frameworks designed to improve patient outcomes. It was already known that automated systems could potentially assist in managing complex treatment regimens. Researchers have long sought ways to minimize human error during the administration of life-sustaining hormone therapies. These persistent challenges highlight the need for evaluating modern software solutions in standard medical practice.

Purpose Of The Study:

The aim of this review is to evaluate the advancement of computational intelligence within the field of metabolic disease management. Researchers sought to understand how these tools assist in the prediction and monitoring of glucose levels. The study addresses the challenge of managing chronic conditions that lack a definitive cure. Authors investigated the role of automated systems in guiding insulin administration for patients. The work explores how digital solutions can mitigate the risk of long-term systemic complications. The team examined the potential for these technologies to support physicians in early diagnostic processes. This investigation was motivated by the need to reduce medical errors in complex treatment environments. The review provides a comprehensive look at how modern software is transforming standard clinical approaches to care.

Main Methods:

Review Approach involved a systematic synthesis of current literature regarding computational advancements in metabolic health. The authors evaluated peer-reviewed studies focusing on software integration and automated medical devices. This investigation prioritized research demonstrating practical applications in glucose regulation and hormone delivery. The team examined how these digital tools interact with existing clinical diagnostic workflows. Researchers scrutinized data concerning the reduction of human error in therapeutic administration. The study design focused on identifying trends in predictive modeling for chronic condition management. Investigators synthesized findings from diverse clinical trials to assess the efficacy of these modern interventions. This methodology allowed for a broad overview of how technology influences current medical standards.

Main Results:

Key Findings From the Literature indicate that computational models successfully assist in predicting glucose fluctuations and guiding hormone delivery. The authors report that these systems effectively minimize the risk of secondary complications like neuropathy and nephropathy. Evidence shows that software-based interventions significantly reduce medical errors during the management of complex treatment regimens. The review highlights that early diagnosis is improved through the application of advanced pattern recognition algorithms. Findings suggest that continuous monitoring devices provide more reliable data than traditional intermittent testing methods. The literature confirms that these tools support physicians by streamlining the decision-making process for patient care. Results demonstrate that integrating these technologies leads to more efficient management of chronic metabolic states. The authors conclude that the current evidence supports the continued adoption of these digital solutions in clinical practice.

Conclusions:

Synthesis and Implications suggest that computational tools offer significant potential for improving patient-centered metabolic monitoring. The authors propose that automated systems could effectively reduce the incidence of secondary organ damage. Evidence indicates that software-driven guidance for hormone administration enhances the precision of daily therapeutic routines. The review highlights that early detection capabilities provided by these models assist clinicians in optimizing treatment plans. Authors note that minimizing human error remains a primary benefit of integrating these advanced digital platforms. The literature indicates that ongoing development of specialized devices will likely expand the reach of these interventions. Researchers emphasize that these technologies serve as supportive aids rather than replacements for professional medical judgment. The synthesis confirms that digital health advancements represent a promising frontier for enhancing long-term quality of life.

The researchers propose that these systems improve outcomes by providing precise insulin injection guidance and continuous glucose monitoring. This dual approach helps patients maintain target blood sugar levels, thereby lowering the risk of developing severe conditions like retinopathy or nephropathy compared to traditional manual tracking methods.

The authors identify Artificial Intelligence-based devices as a key component for real-time data analysis. These tools differ from standard software by offering active, automated feedback loops that assist physicians in early diagnosis, whereas conventional electronic records merely store historical patient information without providing predictive insights.

The authors suggest that high-resolution data streams are necessary for effective predictive modeling. This technical requirement ensures that algorithms can detect subtle fluctuations in blood glucose, which is critical for preventing the acute medical errors often associated with manual dosage calculations in clinical settings.

The researchers describe software as the foundational layer for processing complex physiological signals. While hardware components capture raw metrics, the underlying algorithms perform the essential task of translating these inputs into actionable clinical recommendations for both patients and their attending healthcare providers.

The authors note that the phenomenon of early diagnosis is significantly enhanced through machine learning pattern recognition. This capability allows for the identification of metabolic abnormalities sooner than standard screening protocols, which rely on periodic laboratory tests that may miss transient glucose spikes.

The researchers propose that these advancements will lead to a paradigm shift in how physicians approach chronic disease. They claim that by reducing diagnostic delays and treatment inaccuracies, these tools will ultimately transform the standard of care for patients requiring lifelong metabolic support.